Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

Miller, E. J., SALISBURY, D. M., & Ramsay, M. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 483

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 409

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

Ramsay, M. E., Andrews, N. J., Kaczmarski, E. B., & Miller, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03594-7 · Cited by 337

Estimating Haemophilus influenzae Type b Vaccine Effectiveness in England and Wales by Use of the Screening Method

Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172

Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom

Borrow, R., Goldblatt, D., Andrews, N. J., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K. A. V., & Miller, E. (2002) · The Journal of Infectious Diseases · doi:10.1086/344324 · Cited by 114

TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines

Calle, I. R., Rial, J. G., Bont, L., Gessner, B. D., Kohn, M. A., Dagan, R., Payne, D. C., Bruni, L., Pollard, A. J., García‐Sastre, A., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1788301 · Cited by 1

Historical review of vaccination against meningococcus in Spain (1996–2021). Learned lessons

Valls-Arévalo, A., de Alba, A. F., López-Martín, D., Goycochea-Valdivia, W. A., Cano, I. M., de Villalta, M. G.-F., de la Cueva, I. S., & Garcés‐Sánchez, M. (2023) · Vacunas (English Edition) · doi:10.1016/j.vacune.2023.01.003 · Cited by 1

Aspectos epidemiológicos da doença meningocócica no Distrito Federal, 2000 a 2011

Tauil, M. D. C. (2013) · doi:10.11606/d.6.2013.tde-14032013-131623 · Cited by 1

Changes to the childhood immunization programme

Noakes, K., Moreton, J., & SALISBURY, D. M. (2006) · British Journal of School Nursing · doi:10.12968/bjsn.2006.1.2.22390 · Cited by 1

Nuevas estrategias con vacuna conjugada frente a meningitis por meningococo de serogrupo C: ¿una historia interminable?

Vázquez, J. A. (2006) · Vacunas · doi:10.1016/s1576-9887(06)73190-9 · Cited by 1

ImmunogenicityofaTetravalentMeningococcal Glycoconjugate Vaccine in Infants

Snape, M. D., Perrett, K. P., Ford, K. J., John, T. M., Pace, D., Langley, J. M., McNeil, S., Dull, P. M., Ceddia, F., Anemona, A., et al. (2006) · 44th Annual Meeting · Cited by 1

Trends in Pediatric and Neonatal Critical Care in the Next 10 Years

Tasker, R. C. (2005) · Springer eBooks · doi:10.1007/3-540-29730-8_8 · Cited by 1

Synthesis of fragments of the capsular polysaccharide of Neisseria meningitidis (serogroup A) suitable for bioconjugation

Black, A. L. (2014) · Cited by 1

Efetividade da vacina conjugada contra o meningococo C em menores de dois anos

Conde, M. T. R. P. (2014) · doi:10.11606/t.6.2014.tde-03112014-085727 · Cited by 1

Vacunaciones de recuerdo: ¿puede la memoria inmunológica adelantarse a la patogénesis de la enfermedad?

Pichichero, M. E. (2009) · PEDIATRICS

Enfermedad meningocócica. Un estudio de caso control en Ciudad Habana, noviembre 2003-julio 2005

Pérez, A. E., Zamora, R., & Pajón, R. (2011) · Vaccimonitor/VacciMonitor

Une étude de la réponse des cellules B mémoires au vaccin polysaccharidique conjugué contre le méningocoque du sérogroupe C

Blanchard Rohner, G. (2006) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:444

Varying vaccination schedules: do all roads lead to Rome?

Wiedermann, U. (2009) · Monatsschrift Kinderheilkunde

A capsular vaccine candidate for non-typhoidal Salmonella

Perera, S. R. (2015) · University Library - University of Saskatchewan (University of Saskatchewan)

The New Generation of Meningococcal Conjugate Vaccines: Rationale and Global Potential

Miller, J. M., POOLMAN, J. T., & Boutriau, D. (2009)

Meningococcal disease: is it a latent disease in Mexico?

Barreto, D. G., Monteros, L. E. E. D. L., Espinosa, S. M., Cruz, E. C., Mata-Miranda, P., & Rodríguez-Suárez, R. S. (2010) · Boletín Médico del Hospital Infantil de México

Enfermedad meningocócica por serogrupo C en un niño vacunado con vacuna antimeningocócica C conjugada

Salinas, Z. L., Sert, S. Z., Costas, J. S., Badia, M. G., Falcó, S. N., & Llop, F. A. M. (2006) · Vacunas · doi:10.1016/s1576-9887(06)73207-1

Estrategias vacunales con pautas abreviadas

Vilella, A., & Bayas, J. M. (2005) · Vacunas · doi:10.1016/s1576-9887(05)72994-0

Vacuna antimeningocócica conjugada tetravalente

Roman, Y. M., & Campins, M. (2011) · Anales de Pediatría Continuada · doi:10.1016/s1696-2818(11)70018-x

Pain and heavy bleeding with intrauterine contraceptive devices

Rose, S. B. (2007) · BMJ · doi:10.1136/bmj.39288.584086.80

New vaccines for children

Cottis, H., & Finn, A. H. R. (2008) · Paediatrics and Child Health · doi:10.1016/j.paed.2008.08.003

On the neisserial vaccine quest:NeisseriaVaccines 2007

Pajón, R., Niebla, O., Yero, D., Pérez, O., Cabrera, O., Findlow, J., Balmer, P., & Borrow, R. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.4.545

Het niet-pluisgevoel bij ernstige infecties van kinderen

den Bruel, A. V., Thompson, M. J., Buntinx, F., & Mant, D. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0287-8

The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global

Initiative, M. (2013)

Studies on bacterial respiratory pathogens causing bacteraemia and meningitis in South Africa

Gottberg, A. M. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)

Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention

Casa, S., & Preto, R. (2010)

ReviewArticle Neonatal and Infantile Immune Responses to Encapsulated Bacteria and Conjugate Vaccines

Klouwenberg, P. M. C. K., & Bont, L. (2008)

Analysis of the Genetic Diversity of Neisseria Meningitidis in South Africa

Coulson, G. B. (2006) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)

Schutzimpfung gegen invasive Meningokokkeninfektionen

Kommission für Infektionskrankheiten und Impffragen der Deutschen Akademie für Kinder- und Jugendmedizin e.V., B., & Niethammer, D. (2006) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-006-1332-5

Maintaining protection against invasive bacteria with protein- polysaccharide conjugate vaccines

Cohn, M. L., Libero, G. D., Gascoigne, N. R. J., Hoefer, T., Jameson, S. C., Luescher, I. F., Mallaun, M., & Mescher, M. F. (2009)

Meningococcal conjugate vaccines: efficacy and new combinations Vacinas meningocÛcicas conjugadas: eficÆcia e novas combinaÁies

AurØlio, M., & Barros, P. (2006)

Weitreichende Möglichkeiten der Impfprävention

Knuf, M. (2014) · Pädiatrie · doi:10.1007/s15014-014-0456-7

Meningococcal and Pneumococcal Meningitis in Northern Ghana

Fakultät, P.-N. (2007)

Usefulness of porA sequencing in distinguishing sporadic and linked cases of serogroup B invasive meningococcal disease in Suffolk, United Kingdom, December 2009 to January 2010

Varadarajan, A., Sundkvist, T., Jayatilleke, N., Williams, C. J., Gray, S. J., Carr, A. D., & Kaczmarski, E. B. (2011) · Eurosurveillance · doi:10.2807/ese.16.04.19775-en

FACULTE DE MEDECINE ET DE PHARMACIE DE ROUEN

François, A., Boyer, O., & Guerrot, D. (2015)

Imunogenicidade de antígenos de vesículas de membrana externa (OMVs) de Neisseria meningitidis B associada a lípide catiônico (DDA-BF).

Rinaldi, F. M. (2014) · doi:10.11606/d.87.2014.tde-08122014-092828

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy

Pace, D., Khatami, A., Attard-Montalto, S., Voysey, M., Finn, A. H. R., Faust, S. N., Heath, P. T., Borrow, R., Snape, M. D., & Pollard, A. J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.038

Systematic analysis of fHbp sequence coverage by antibodies against meningococcal GMMA from african group W strains

Aruta, M. G. (2016)

Vaccines Research and Vaccination

(2018) · Vaccines Research & Vaccination · doi:10.24966/vrv-0193

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence

Stoof, S. P., van Ravenhorst, M. B., van Rooijen, D. M., de Voer, R. M., van der Klis, F. R. M., Boland, G. J., Sanders, E. A. M., Berbers, G. A. M., & Teunis, P. F. M. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00429-16

RECOMMANDATIONS CONCERNANT L'ADMINISTRATION DES VACCINS CONJUGUÉS CONTRE LE MÉNINGOCOQUE DE SÉROGROUPE C AUX NOURRISSONS

Conjugate, M. C. (2007)

Investigation into Self-Assembling Microcrystals as an alternative to polysaccharide-based conjugate vaccines

Lavelle, S.-W. (2016) · UCL Discovery (University College London)

La vaccination contre le méningocoque : des lignes directrices et le problème du taux de vaccination

Salvadori, M. I., & Fisher, W. A. (2012) · Paediatrics & Child Health · doi:10.1093/pch/17.suppl_c.9a

Meningococcal Immunization: Guidelines and Issues of Vaccine Uptake

Salvadori, M., & Fisher, W. F. (2012) · Paediatrics & Child Health · doi:10.1093/pch/17.suppl_c.9

Vaccines Against Central Nervous System Infections: Past Achievements and Future Challenges

Sadarangani, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813806-9.00004-4

Conseil pour considération du vaccin conjugué quadrivalent contre le méningocoque (A, C, Y, W135) pour utilisation par les provinces et territoires

d’immunisation, C. C. (2010) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v36i00as2f

Management of meningococcal outbreaks: are we using the same language? Comparison of the public health policies between high-income countries with low incidence of meningococcal disease

Burmaz, T., Guicciardi, S., Selle, V., Lopalco, P. L., Baldo, V., & Fantini, M. P. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1595595

Prevalência e fatores associados ao estado de portador de Neisseria spp. em núcleos familiares: estudo de base populacional

Lima, J. C. (2019) · doi:10.11606/t.6.2019.tde-22032019-160734

Vaccines for the Prevention of Admission to the Pediatric Intensive Care Unit

Segal, S., Snape, M. D., Kelly, D. L. F., & Pollard, A. J. (2008) · Springer eBooks · doi:10.1007/978-1-84628-917-0_5

Novel Complement Blocking Antibodies Against Serogroup B N. meningitidis: A Dissertation

Ray, T. D. (2010) · eScholarship@UMassChan · doi:10.13028/kwp1-3r83

Doença meningocócica no Brasil : descrição de casos, evidência da efetividade e do impacto da vacina anti-meningocócica conjugada sorogrupo C, 2001 – 2013

de Moraes, C. (2016) · doi:10.26512/2016.10.t.22773

Meningococcemia

Domingo, P., & Barquet, N. (2007) · Springer eBooks · doi:10.1007/978-3-540-34406-3_33

Neisseria meningitidis

Baudner, B. C., & Rappuoli, R. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8412-6_12

Impfungen für das Immungedächtnis – immer wieder oder einmalig?

Lehmann, C. (2022) · Der Internist · doi:10.1007/s00108-022-01324-w

Systemic Sepsis

Isaacs, D., Elliott, E. J., Gilbert, R. E., Moyer, V. A., & Pichichero, M. E. (2007) · doi:10.1002/9780470692172.ch15

Vacunas antimeningocócicas

Navarro-Alonso, J.-A. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76222-0

Vaccines for international travel

Barnett, E. D., Kozarsky, P. E., & Steffen, R. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50069-6

Meningococcal Vaccines

Pollard, A. J., Snape, M. D., & Sadarangani, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-77173-7_22

Meningococcal Vaccines

Pollard, A. J., Snape, M. D., & Sadarangani, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-59952-6_22

Revisión histórica de la vacunación frente a meningococo en España (1996-2021). Lecciones aprendidas

Valls-Arévalo, A., de Alba, A. F., López-Martín, D., Goycochea-Valdivia, W. A., Cano, I. M., de Villalta, M. G.-F., de la Cueva, I. S., & Garcés‐Sánchez, M. (2022) · Vacunas · doi:10.1016/j.vacun.2022.10.003

Vaccines for International Travel

Barnett, E. D., Kozarsky, P. E., & Steffen, R. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00071-2

Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines

Klugman, K. P., Malley, R., & Whitney, C. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00047-5

Immunogenicity, safety and immunological memory of a Brazilian meningococcal C conjugate vaccine on a phase II clinical trial

Martins, R. D. M., Marques, C., de Noronha, T. G., Engstrom, E. M., Sepúlveda, C. D. S., Camacho, L. A. B., Matos, D. C. D. S., da Silva, A. M. V., Leal, M. D. L. M., Jessouroun, E., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127419

Meningokokki ja uuden polven rokotteet

Hietalahti, J. (2014) · Työväentutkimus Vuosikirja

Additional file 2 of Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs

Tin Tin Htar, M., Jackson, S., Balmer, P., Serra, L., Vyse, A., Slack, M., Riera-Montes, M., Swerdlow, D. L., & Findlow, J. (2020) · Figshare · doi:10.6084/m9.figshare.13357416

Additional file 1 of Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs

Tin Tin Htar, M., Jackson, S., Balmer, P., Serra, L., Vyse, A., Slack, M., Riera-Montes, M., Swerdlow, D. L., & Findlow, J. (2020) · Figshare · doi:10.6084/m9.figshare.13357413

Epidémie clonale d'infections invasives à méningocoque de groupe B en Normandie : caractérisation d'un facteur de virulence - HmbR, système d'acquisition du fer via l'hémoglobine - et analyse de la protection conférée par un vaccin à base de vésicules de membrane externe

Sevestre, J. (2018) · doi:10.70675/269fada9zf58cz4ad8zb125z8b1aa204c23e

Immunogenicity, Reactogenicity, and Safety of CRM197-Conjugated Meningococcal A, C, W, Y Vaccine: Multicenter, Randomized, Phase III Trial

Namazova-Baranova, L. S., Fedoseenko, М. V., Efendieva, K. E., Kaliuzhnaia, T. A., Васильевна, Т. С., Месроповна, С. А., Костинов, М. П., Фельдблюм, И. В., Vilnits, A. A., Михайловна, Х. С., et al. (2026) · Вопросы современной педиатрии · doi:10.15690/vsp.v25i4.3094

C2 Fragment from Neisseria meningitidis Antigen NHBA Disassembles Adherence Junctions of Brain Microvascular Endothelial Cells

Casellato, A. (2013) · Padua@research (University of Padova)

New vaccines for travelers

Haditsch, M. (2005) · Wiener klinische Wochenschrift · doi:10.1007/s00508-005-0441-9

Updated post-licensure surveillance of meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlate of protection and modelling predictions of the duration of herd immunity

Campbell, H., Andrews, N., Borrow, R., Trotter, C., & Miller, E. (2010) · Bristol Research (University of Bristol)

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

Campbell, H. J., Andrews, N. J., Borrow, R., Trotter, C. L., & Miller, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00529-09 · Cited by 213

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological

(2010)

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

Borrow, R., & Miller, E. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.6.851 · Cited by 58

Meningococcal C conjugate vaccine: the experience in England and Wales

Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168